Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

European shares fall, led by banks and drugmakers

Published 06/25/2009, 07:44 AM
Updated 06/25/2009, 07:48 AM
UK100
-
TLIT
-
CSGN
-
NOVN
-
PSHG_p
-
TEL
-
BOUY
-
CAGR
-
HMb
-
TELIA
-
VOD
-
GSK
-
STAN
-

* FTSEurofirst 300 falls 1.3 percent

* Standard Chartered, other banks fall

By Harpreet Bhal

LONDON, June 25 (Reuters) - European shares fell by midday on Thursday after data showing a record decline in euro zone industrial orders dimmed hopes that the economic downturn may soon come to an end.

At 1120 GMT, the FTSEurofirst 300 was 1.3 percent lower at 842.22 points, giving back some of the 2.4 percent gain posted in the previous session.

The index has rebounded more than 30 percent since hitting a record low on March 9, and is on track to post the best quarterly gain since late 1999, but is still down 48 percent from the multi-year peak reached in mid-2007.

"The equities market had been a one-way bet but now there are doubts about the recovery, given recent forecasts from the World Bank and the OECD," said Jeremy Batstone-Carr, strategist at Charles Stanley.

"This is the time of year when analysts revise their earnings for next year. They had earnings growth of 20 percent for 2010, but given the backdrop, that looks unlikely." Investors nerves were also rattled by comments on Wednesday from the Federal Reserve, which warned that U.S economic weakness would remain for a time while keeping interest rates close to zero.

Banks were a major drag on the index. Standard Chartered fell 3.1 percent after the Asia-focused lender reported record levels of income and profit in the first five months of this year but warned wholesale credit quality had deteriorated in the second quarter..

HSBC, which also has a strong Asia focus, fell 1.4 percent. UBS and Credit Suisse shed between 4.3 and 3.5 percent. French bank Credit Agricole dropped 4.9 percent on market talk that the lender's results could come in lower than analysts' consensus, traders said. A spokesman for the bank declined to comment.

Drugmakers were also under pressure, led by falls in Sanofi-Aventis, which shed 2.9 percent, as analysts cited concerns that its key blockbuster diabetes treatment Lantus might be linked to cancer risk. Officials at Sanofi said the drug was safe.

GlaxoSmithKline and Novartis fell 1.2 and 2.5 percent respectively.

Telecoms stocks fell after Goldman Sachs downgraded the European telecom services sector to "neutral" from "attractive".

Vodafone, Telenor and TeliaSonera shed between 1.1 and 1.7 percent.

Bucking the trend, shares in Telecom Italia gained 3 percent, supported by an upgrade to "buy" from "neutral" by Milan broker Equita, and as Goldman Sachs added the stock to its "Conviction Buy list".

Energy shares were mostly lower. Royal Dutch Shell fell 1.3 percent after Nigeria's main militant group raided its pipeline and disrupted a major export terminal.

BASF, the world's largest chemicals maker, fell 3.3 percent after saying it will dismantle a plant producing plastics for packaging, stepping up efforts to cut capacity as demand shows little signs of recovery.

BOUYGUES GAINS

Among the gainers, France's Bouygues rose 3.7 percent after Goldman Sachs upgraded its rating on the stock to "buy" from "neutral".

Swedish clothing retailer Hennes & Mauritz gained 1.4 percent after posting second-quarter profits above market expectations.

Porsche surged 4.6 percent, propelled by renewed speculation that the carmaker was close to a deal with Qatar to give the Gulf state a shareholding in Volkswagen, a move that would clear the way for the two German manufacturers to merge.

Around Europe, UK's FTSE 100 index was down 0.8 percent, Germany's DAX index down 1.4 percent, and France's CAC 40 down 1.3 percent.

Pessimism about the pace of economic recovery intensified as euro zone new industrial orders plunged 35.5 percent year-on-year in April, a record decline led by falling demand for capital and immediate goods

Orders fell 1.0 percent month-on-month. Economists polled by Reuters had expected a flat monthly reading and a 32.3 percent year-on-year fall.

(Additional reporting by Brian Gorman; Editing by John Stonestreet)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.